266 results about "Particulate suspension" patented technology

The present invention relates to droplet-based particle sorting. According to one embodiment, a droplet microactuator is provided and includes: (a) a suspension of particles; and (b) electrodes arranged for conducting droplet operations using droplets comprising particles. A method of transporting a particle is also provided, wherein the method includes providing a droplet comprising the particle and transporting the droplet on a droplet microactuator.

Apparatus for sensing and characterizing particles (e.g., blood cells or ceramic powders) suspended in a liquid medium comprises a conduit through which the particle suspension is caused to pass simultaneously with an electrical current. According to the invention, the interior wall of the conduit effectively varies in resistivity along the length of the conduit to define a delimited central region of high electrical resistivity which is smoothly contiguous on its opposing boundaries to uninsulated distal elements of lesser electrical resistivity. The delimited central region of the conduit functions as a Coulter volumeter conduit. The uninsulated distal elements of the conduit are made to have a dimension along the conduit wall which is at least equal to the axial extent of the effective ambit electric fields of a traditional Coulter volumeter conduit having a cross-sectional geometry identical to that of the delimited central region of high resistivity in the improved volumeter conduit. According to a preferred embodiment of the invention, the delimited central region of the improved volumeter conduit is defined by a traditional Coulter conduit wafer, i.e., a dielectric wafer containing a central circular conduit, and the distal elements of lesser resistivity are defined by uninsulated, electrically conductive, circular collars attached to opposite sides of the conduit wafer. The conduit in the conduit wafer and the openings in the conductive collars collectively form a hydrodynamically smooth volumeter conduit, in which the electric and hydrodynamic fields of the traditional volumeter conduit are advantageously amended in the manner above noted.

The present invention provides a method for preparing submicron-sized particles. The method includes the steps of: (1) providing a multiphase system having an organic phase and an aqueous phase, the organic phase having a pharmaceutically effective compound therein; and (2) sonicating the system to evaporate a portion of the organic phase to cause precipitation of the compound in the aqueous phase and having an average effective particle size of less than about 2 m.

The invention provides injection vehicles suitable for administering particulate suspensions, such as polymer-based formulations, as well as associated pharmaceutical formulations, articles of manufacture, and kits. Other aspects of the invention included methods for producing and administering pharmaceutical formulations. The injection vehicles of the invention are superior to conventional injection vehicles in that they include a pseudoplastic composition that improves injectability, which facilitates delivery of the desired dose. The injection vehicles of the invention also allow the use of smaller-bore needles than are usually necessary to inject polymer-based formulations, reducing the pain associated with injection of such formulations.

A syringe having two or more chambers having a needle defining two or more lumens for injecting a microparticle suspension into a desired space, the lumens being in fluid communication with respective chambers. One of the chambers has the microparticle suspension disposed therein while the other chamber is empty. The lumen in fluid communication with the empty chamber has a filter element disposed therein such that the suspension fluid may be withdrawn from the space into the empty chamber without withdrawing the microparticles.

An objective of the invention is to provide a method for producing a polymer-particle composite by which a polymer-particle composite having a desired particle density and a desired film thickness can be produced conveniently without allowing the particle to be aggregated in the polymeric matrix. To accomplish the objective described above, the present invention provides a method for producing a polymer-particle composite comprising a step of forming a polymer-containing layer mainly consisting of a polymeric material and a step of bringing a particle suspension containing the particle suspended in a solvent capable of swelling the polymeric material into contact with the polymer-containing layer.

The invention relates to a latex enhanced immunoturbidimetry kit for the detection of asymmetric dimethylarginine content. Specifically, the invention relates to a latex enhanced immunoturbidimetry kit for the detection of asymmetric dimethylarginine (ADMA) content in human blood samples. The kit comprises a mouse anti-human monoclonal antibody solution, an ADMA-human Serum albumin complex crosslinked latex particle expansion and an ADMA calibrator. According to the method, by the utilization of competitive binding of free ADMA in blood and ADMA crosslinked on the surface of latex particles to ADMA monoclonal antibody, turbidity formed by the reaction between the ADMA-crosslinked latex particles and ADMA monoclonal antibody is reduced. Therefore, the content of ADMA is detected through the reduction degree of turbidity. The kit provided by the invention can be applied in a biochemical analyzer commonly-used in clinic, is convenient and rapid to operate and has strong specificity. Both sensitivity and detection range of the kit can satisfy clinic application needs.

The invention belongs to the technical field of preparation of a microcapsule, and relates to a latent self-repair microcapsule for an organic coating and a preparation method of the latent self-repair microcapsule. The method comprises the steps of feeding urea and formaldehyde mixed solution into a four-mouth flask, adjusting the pH value to 7.5-11.8 with triethanolamine, and ensuring that the temperature is slowly increased for reaction for 3 hours, so as to produce viscous transparent water-soluble urea-formaldehyde prepolymer solution; sufficiently mixing a capsule-core epoxy resin, a capsule-core diluting agent, and a capsule-core latent curing modifier proportionally, adding distilled water, stirring, adding an emulsifying agent, emulsifying for 10-20min in a high-speed emulsifyingmachine, so as to form O/W type emulsion, mixing the urea-formaldehyde prepolymer solution and the emulsified liquid and sufficiently stirring to disperse in an aqueous medium, adjusting the pH valueto 1.0 to 5.0, centrifugating the particle suspension after curing at a controlled temperature for 3 hours, performing flushing for a plurality of times, and then performing vacuum drying to obtain the microcapsule. The method has the advantages that the technology is simple, the condition is easy to control, the preparation cost is low, the product quality is good, the repair effect is good, themanpower and cost are saved, and the method is environment-friendly.

The present invention provides formulations useful for treating infections, in particular, formulations that include the active pharmaceutical ingredient Posaconazole in an injectable suspension of particles that is stable when subjected to terminal sterilization. Preferred median particle sizes of between 1.5 and 3.0 microns are found to result in superior pharmacokinetic characteristics, such as those displayed below.

The present invention relates to a method of particle separation comprising preparing a suspension of particles containing at least one recognizable target particle in a suspending solution, labeling the target particle with a conjugate marker, wherein the conjugate marker comprises at least one recognition unit for the recognizable target particle and at least one peroxidase enzyme, contacting a gelatin surface with the suspending solution, adding developer to the suspending solution in contact with the gelatin surface and in the presence of phenol to attach the target particle to the gelatin surface, and washing the gelatin surface to remove unattached particles. The method may also include detecting the presence of the target particle on the gelatin surface as well as detaching and recovering the attached particles after removal of the non-target particles.

The present invention relates to processes for forming particles including drugs in a solution, changing the bulk or surface properties of a drug particle, and/or microencapsulation drug particles, and compositions produced thereby. In some embodiments, the process described utilized mechanical agitation, more specifically low-frequency sonication, under controlled conditions, which provides mild shear forces during forming and/or precipitation to control the particle growth and mixing properties. Particle size can range from less than about 200 nanometers to greater than about one millimeter, depending on the processing conditions and application. The process described can be used to form a drug particle suspension, dry a wet powder slurry or suspension, as well as to improve the surface properties of the particle through conditioning the structure of the particle or particle surface and/or annealing the particle or particle surface. Annealing or conditioning drug particles may be used to force an amorphous to crystalline transition, creating a more stable powder, or smooth a particle surface. In addition, the process can be used to microencapsulate particles by suspending the microparticles in a non-solvent including a coating material (such as a biodegradable polymer) under controlled process conditions. The powder compositions produced thereby possess improved properties including, but not limited to, improved flow and dispersibility, controlled bioadhesion, stability, resistance to moisture, dissolution/release profiles, and/or bioavailabilities. This process, and the compositions produced, provide significant advantages in the manufacture of pharmaceutical particulate formulations, as well as biomedical, diagnostic, and chromatography particulate compositions, where sensitive macromolecules, such as proteins or DNA, are involved that would be degraded using more rigorous processing conditions or temperatures.

An electrolytic filtration method and apparatus for the concentration and collection of suspended particulates from aqueous solutions is disclosed. The electrolytic cell contains at least an anode and a cathode, and in one embodiment contains a plurality of anodes and cathodes. The electrolytic cell also contains a filter, and in one embodiment the filter is a moving belt filter. While not bound by theory, the electrolytic filtration method and apparatus is based on the electrophoretic movement of algae particles suspended in an aqueous solution away from the filter under the influence of an electric field. In one embodiment the electric field is a pulsed waveform with unidirectional voltage or current pulses. In another embodiment, the electric field is a pulsed waveform with bidirectional voltage or current pulses.

A system for monitoring non-volatile residue concentrations in ultra pure water includes a nebulizer for generating an aerosol composed of multiple water droplets, a heating element changing the aerosol to a suspension of residue particles, and a condensation particle counter to supersaturate the dried aerosol to cause droplet growth through condensation of a liquid onto the particles. The nebulizer incorporates a flow dividing structure that divides exiting waste water into a series of droplets. The droplets are counted to directly indicate a waste water flow rate and indirectly indicate an input flow rate of water supplied to the nebulizer. The condensation particle counter employs water as the condensing medium, avoiding the need for undesirable chemical formulations and enabling use of the ultra pure water itself as the condensing medium.

The present invention relates to active substances in particulate form, to methods for preparing them, to formulations containing them and to uses of such substances and formulations. A preferred embodiment is directed to particulate suspensions having improved flocculation behaviour in a suspension vehicle, such as a hydrofluoroalkane propellant used in metered dose inhalers.

To provide a magnetic particle parallel processing apparatus permitting repeated use of a container, and a method of magnetic particle parallel processing permitting repeated use of a container, with which the rate of repeated use of a container is enhanced to thereby achieve a saving in the working space and a saving in the working time. The apparatus comprises: at least one reaction container; a liquid disposal tank; a reagent etc. feeder with at least one flow channel for feeding at least one type of liquid selected from the group consisting of two or more types of solutions and a magnetic particle suspension according to the processing content, at a given amount and at a given timing, to the reaction container; and a magnetic separator which has at least one processing nozzle with a distal end insertable into the reaction container and the liquid disposal tank, for sucking and discharging a liquid through the distal end, and which also has a magnetic means capable of applying a magnetic field to the interior of the distal end to thereby attract magnetic particles contained in the liquid inside the distal end to the inner wall thereof to effect separation of the magnetic particles, and canceling the magnetic field to thereby release the attracted magnetic particles and re-suspend the same in a liquid.

The invention discloses a graphene/carbon nano tube hybridized filler network enhanced rubber material and a preparation method thereof. According to the rubber material, graphene and carbon nano tubes are taken as filler, a hybridized filler network is formed in a rubber material matrix, wherein 100 parts by mass of the rubber material matrix are adopted, and 0.1-20 parts by mass of graphene and the carbon nano tubes are adopted. The rubber material is prepared according to steps as follows: oxidized graphene and the carbon nano tubes are added to water, and a hybridized suspension liquid is prepared; the prepared hybridized suspension liquid is added to an emulsion of the rubber material matrix and mixed, a demulsifier is added for demulsification, an oxidized graphene/carbon nano tube/rubber particle suspension liquid is prepared, then, a reducing agent is added for a reduction reaction, solid-liquid separation is performed after sufficient reaction, an obtained solid phase is washed and dried, and the rubber material is prepared. The graphene and the carbon nano tubes form the hybridized filler network in the rubber material and have an energy dissipation function, so that the rubber material has excellent mechanical property, fatigue resistance, crack growth resistance and conductive property.

The invention discloses a Beta-FeOOH nanoparticle suspension preparation method, relating to a preparation method of an enhanced heat transfer medium, in particular to a stable Beta-FeOOH nanoparticle suspension. The method comprises the steps as follows: firstly, the aqueous solution of ferric trichloride and urea is prepared, wherein, the mass ratio of the ferric trichloride and the urea is 6:1; and then the aqueous solution is added into an airtight PTFE reactor, reacted at the temperature of 80 plus or minus 2 DEG C till the end, and naturally cooled to room temperature, so that the Beta-FeOOH nanoparticle suspension is obtained. The method adds no stabilizing agent, and the produced Beta-FeOOH is small in size and good in uniformity and stability. The method has the advantages of small number of production equipment, simple operating steps, low cost, and requires no additives except raw materials, thus being suitable for industrial production.

The invention provides a preparation method of electromagnetic composite hollow microspheres, relates to a preparation method of a composite hollow material and aims to solve the problems of poor conductivity, high density and high falling possibility of magnetic particles of the existing composite hollow material. The preparation method comprises the following steps: 1, preparing polystyrene microspheres; 2, dispersing the polystyrene microspheres in concentrated sulfuric acid, and sulfonating; 3, preparing a magnetic Fe3O4 nano particle suspension; 4, adding the sulfonic-group-containing SPS microspheres and the Fe3O4 nano particle suspension into a water solution; 5, adding ethanol and ammonia water, and dropwisely adding ethyl orthosilicate; 6, adding into a PVP-containing ethanol solution, and stirring; and 7, mixing an aniline solution with the PVP modified magnetic microspheres, dropwisely adding ammonium persulfate, drying, adding N,N-dimethylformamide, and soaking. For the prepared hollow microspheres, the conductivity is 0.01-1.0 S/cm, the density is low, and the magnetic particles are less prone to fall; and the hollow microspheres are mainly used in the fields of light-weight electromagnetic materials, photonic crystals, wave-absorbing materials and the like.

An optical technique to improve the imaging of a target inside suspensions of scattering particles includes the illumination of the scattering particles with circularly polarized light. The backscattered light from the host medium preserves the helicity of incident light, while the backscattered light reflected from the target is predominated with light of opposite helicity. Based on the observed helicity difference in the emerging light that originated at the target and that backscattered from the medium, the present optical technique improves the image contrast using circular polarization. This approach makes use of polarization memory which leads to the reflected light from the target accompanied by weak diffusive backscattered light. Using the present technique, improved imaging of the artery wall is achieved and plaque composition can be assessed through a blood field associated with the artery. The scattering from the particles, such as red blood cells, in the blood is reduced due to polarization memory. The present invention can be also applied to other biomedical application, as well as image targets through adverse environmental conditions, such as fog, clouds, smoke, murky water, etc.